Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Jun 8. doi: 10.1007/s10620-018-5154-9. [Epub ahead of print]

PMID:
29948559
2.

Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China.

Varga MG, Wang T, Cai H, Xiang YB, Gao YT, Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):342-344. doi: 10.1158/1055-9965.EPI-17-1084. Epub 2017 Dec 20.

PMID:
29263184
3.

DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori.

Varga MG, Peek RM.

Curr Top Microbiol Immunol. 2017;400:169-193. doi: 10.1007/978-3-319-50520-6_8. Review.

4.

TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Varga MG, Piazuelo MB, Romero-Gallo J, Delgado AG, Suarez G, Whitaker ME, Krishna US, Patel RV, Skaar EP, Wilson KT, Algood HM, Peek RM Jr.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G852-G858. doi: 10.1152/ajpgi.00175.2016. Epub 2016 Oct 6.

5.

Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine Kinase and Gastric Disease.

Krishna U, Romero-Gallo J, Suarez G, Azah A, Krezel AM, Varga MG, Forsyth MH, Peek RM Jr.

J Infect Dis. 2016 Aug 15;214(4):644-8. doi: 10.1093/infdis/jiw189. Epub 2016 May 10.

6.

Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system.

Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, Hadjifrangiskou M, Peek RM.

Oncogene. 2016 Dec 1;35(48):6262-6269. doi: 10.1038/onc.2016.158. Epub 2016 May 9.

7.

miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC.

Cell Oncol (Dordr). 2016 Feb;39(1):23-33. doi: 10.1007/s13402-015-0247-3. Epub 2015 Oct 12.

8.

Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.

Noto MJ, Boyd KL, Burns WJ, Varga MG, Peek RM Jr, Skaar EP.

Infect Immun. 2015 Oct;83(10):4134-41. doi: 10.1128/IAI.00410-15. Epub 2015 Aug 3.

Supplemental Content

Loading ...
Support Center